Product Information
GYNAZOLE 1 2% CREAM is a brand (anda) product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $23.3446 per GM under NDC 45802039601. Its NADAC has been published 433 times since Aug 19, 2015.
FDA first approved this application on May 18, 2012.
Strength
100 mg/5g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802039601
Classification
Brand (ANDA)
Dosage Form
CREAM
Route
VAGINAL
Effective Date
8/19/2026
Active Ingredients
BUTOCONAZOLE NITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA200923FDA Approved
5/18/2012
On Market Since
4/29/2015
Pharmacological Classes
Price Statistics
The NADAC for GYNAZOLE 1 2% CREAM has been published 433 times since Aug 19, 2015, and over the history we have for it it has risen 76.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $23.3446 per GM |
|---|---|
| All-time high | $23.5488 (Oct 15, 2025) |
| All-time low | $13.2500 (Aug 19, 2015) |
| 52-week high | $23.5488 |
| 52-week low | $23.3446 |
| Median price | $20.7108 |
| Average price | $20.8281 |
| Largest weekly change | +26.3% (May 18, 2016) |
| Weeks tracked | 433 |
| Tracking since | Aug 19, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the butoconazole nitrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GYNAZOLE 1 2% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for GYNAZOLE 1 2% CREAM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $23.3446 per GM (NDC 45802039601), effective Aug 19, 2026.
How has the price of GYNAZOLE 1 2% CREAM changed over time?
Over the history we have for it, the NADAC for GYNAZOLE 1 2% CREAM has risen 76.2%. It has been tracked across 433 weekly CMS publications since Aug 19, 2015.
What are the highest and lowest recorded NADAC prices for GYNAZOLE 1 2% CREAM?
Since Aug 19, 2015, the NADAC for GYNAZOLE 1 2% CREAM has ranged from a low of $13.2500 (Aug 19, 2015) to a high of $23.5488 (Oct 15, 2025), with a median of $20.7108 per GM.
Are there cheaper alternatives to GYNAZOLE 1 2% CREAM?
No other NADAC-published product currently shares the active ingredient and strength of GYNAZOLE 1 2% CREAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GYNAZOLE 1 2% CREAM?
GYNAZOLE 1 2% CREAM (NDC 45802039601) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a brand (anda) product.